184 related articles for article (PubMed ID: 26551725)
1. Metabolic regulation of natural killer cells.
Finlay DK
Biochem Soc Trans; 2015 Aug; 43(4):758-62. PubMed ID: 26551725
[TBL] [Abstract][Full Text] [Related]
2. mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function.
Donnelly RP; Loftus RM; Keating SE; Liou KT; Biron CA; Gardiner CM; Finlay DK
J Immunol; 2014 Nov; 193(9):4477-84. PubMed ID: 25261477
[TBL] [Abstract][Full Text] [Related]
3. mTORC1 regulates CD8+ T-cell glucose metabolism and function independently of PI3K and PKB.
Finlay DK
Biochem Soc Trans; 2013 Apr; 41(2):681-6. PubMed ID: 23514176
[TBL] [Abstract][Full Text] [Related]
4. Immunometabolism of T cells and NK cells: metabolic control of effector and regulatory function.
Poznanski SM; Barra NG; Ashkar AA; Schertzer JD
Inflamm Res; 2018 Oct; 67(10):813-828. PubMed ID: 30066126
[TBL] [Abstract][Full Text] [Related]
5. mTOR signaling in immune cells and its implications for cancer immunotherapy.
Zeng H
Cancer Lett; 2017 Nov; 408():182-189. PubMed ID: 28888995
[TBL] [Abstract][Full Text] [Related]
6. NFκB up-regulation of glucose transporter 3 is essential for hyperactive mammalian target of rapamycin-induced aerobic glycolysis and tumor growth.
Zha X; Hu Z; Ji S; Jin F; Jiang K; Li C; Zhao P; Tu Z; Chen X; Di L; Zhou H; Zhang H
Cancer Lett; 2015 Apr; 359(1):97-106. PubMed ID: 25578782
[TBL] [Abstract][Full Text] [Related]
7. Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.
McQueen B; Trace K; Whitman E; Bedsworth T; Barber A
Immunology; 2016 Mar; 147(3):305-20. PubMed ID: 26661515
[TBL] [Abstract][Full Text] [Related]
8. The mTOR-glycolytic pathway promotes T-cell immunobiology in oral lichen planus.
Wang F; Zhang J; Zhou G
Immunobiology; 2020 May; 225(3):151933. PubMed ID: 32201095
[TBL] [Abstract][Full Text] [Related]
9. mTOR has a developmental stage-specific role in mitochondrial fitness independent of conventional mTORC1 and mTORC2 and the kinase activity.
Kalim KW; Zhang S; Chen X; Li Y; Yang JQ; Zheng Y; Guo F
PLoS One; 2017; 12(8):e0183266. PubMed ID: 28813526
[TBL] [Abstract][Full Text] [Related]
10. mTORC1 alters the expression of glycolytic genes by regulating KPNA2 abundances.
Chen X; Zhu Y; Wang Z; Zhu H; Pan Q; Su S; Dong Y; Li L; Zhang H; Wu L; Lou X; Liu S
J Proteomics; 2016 Mar; 136():13-24. PubMed ID: 26844761
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Dendritic Cell Immune Function and Metabolism by Cellular Nutrient Sensor Mammalian Target of Rapamycin (mTOR).
Snyder JP; Amiel E
Front Immunol; 2018; 9():3145. PubMed ID: 30692999
[TBL] [Abstract][Full Text] [Related]
12. IL-10 Enhances Human Natural Killer Cell Effector Functions via Metabolic Reprogramming Regulated by mTORC1 Signaling.
Wang Z; Guan D; Huo J; Biswas SK; Huang Y; Yang Y; Xu S; Lam KP
Front Immunol; 2021; 12():619195. PubMed ID: 33708210
[TBL] [Abstract][Full Text] [Related]
13. Immunometabolism and natural killer cell responses.
O'Brien KL; Finlay DK
Nat Rev Immunol; 2019 May; 19(5):282-290. PubMed ID: 30808985
[TBL] [Abstract][Full Text] [Related]
14. Inflammasome, mTORC1 activation, and metabolic derangement contribute to the susceptibility of diabetics to infections.
Krakauer T
Med Hypotheses; 2015 Dec; 85(6):997-1001. PubMed ID: 26384528
[TBL] [Abstract][Full Text] [Related]
15. What Fuels Natural Killers? Metabolism and NK Cell Responses.
Gardiner CM; Finlay DK
Front Immunol; 2017; 8():367. PubMed ID: 28421073
[TBL] [Abstract][Full Text] [Related]
16. mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation.
Pollizzi KN; Patel CH; Sun IH; Oh MH; Waickman AT; Wen J; Delgoffe GM; Powell JD
J Clin Invest; 2015 May; 125(5):2090-108. PubMed ID: 25893604
[TBL] [Abstract][Full Text] [Related]
17. mTORC1 Signaling Allows Cancer Cells to Escape Glycolytic Dependency.
Cancer Discov; 2016 May; 6(5):469. PubMed ID: 27056835
[TBL] [Abstract][Full Text] [Related]
18. Reliance on Cox10 and oxidative metabolism for antigen-specific NK cell expansion.
Mah-Som AY; Keppel MP; Tobin JM; Kolicheski A; Saucier N; Sexl V; French AR; Wagner JA; Fehniger TA; Cooper MA
Cell Rep; 2021 Jun; 35(9):109209. PubMed ID: 34077722
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C Virus-Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1.
Goh CC; Roggerson KM; Lee HC; Golden-Mason L; Rosen HR; Hahn YS
J Immunol; 2016 Mar; 196(5):2283-92. PubMed ID: 26826241
[TBL] [Abstract][Full Text] [Related]
20. TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway.
Viel S; Marçais A; Guimaraes FS; Loftus R; Rabilloud J; Grau M; Degouve S; Djebali S; Sanlaville A; Charrier E; Bienvenu J; Marie JC; Caux C; Marvel J; Town L; Huntington ND; Bartholin L; Finlay D; Smyth MJ; Walzer T
Sci Signal; 2016 Feb; 9(415):ra19. PubMed ID: 26884601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
